IBDEI1MD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29121,1,4,0)
 ;;=4^Visceral Aneurysm NEC
 ;;^UTILITY(U,$J,358.3,29121,1,5,0)
 ;;=5^442.84
 ;;^UTILITY(U,$J,358.3,29121,2)
 ;;=^269785
 ;;^UTILITY(U,$J,358.3,29122,0)
 ;;=442.9^^183^1854^11
 ;;^UTILITY(U,$J,358.3,29122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29122,1,4,0)
 ;;=4^Aneurysm NOS
 ;;^UTILITY(U,$J,358.3,29122,1,5,0)
 ;;=5^442.9
 ;;^UTILITY(U,$J,358.3,29122,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,29123,0)
 ;;=443.0^^183^1854^71
 ;;^UTILITY(U,$J,358.3,29123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29123,1,4,0)
 ;;=4^Raynaud's Syndrome
 ;;^UTILITY(U,$J,358.3,29123,1,5,0)
 ;;=5^443.0
 ;;^UTILITY(U,$J,358.3,29123,2)
 ;;=^103165
 ;;^UTILITY(U,$J,358.3,29124,0)
 ;;=444.21^^183^1854^93
 ;;^UTILITY(U,$J,358.3,29124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29124,1,4,0)
 ;;=4^Upper Extremity Embolism
 ;;^UTILITY(U,$J,358.3,29124,1,5,0)
 ;;=5^444.21
 ;;^UTILITY(U,$J,358.3,29124,2)
 ;;=^269789
 ;;^UTILITY(U,$J,358.3,29125,0)
 ;;=444.22^^183^1854^55
 ;;^UTILITY(U,$J,358.3,29125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29125,1,4,0)
 ;;=4^Lower Extremity Embolism
 ;;^UTILITY(U,$J,358.3,29125,1,5,0)
 ;;=5^444.22
 ;;^UTILITY(U,$J,358.3,29125,2)
 ;;=^269790
 ;;^UTILITY(U,$J,358.3,29126,0)
 ;;=451.11^^183^1854^69
 ;;^UTILITY(U,$J,358.3,29126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29126,1,4,0)
 ;;=4^Phleb/Thrombophl Fem V Deep
 ;;^UTILITY(U,$J,358.3,29126,1,5,0)
 ;;=5^451.11
 ;;^UTILITY(U,$J,358.3,29126,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,29127,0)
 ;;=451.19^^183^1854^42
 ;;^UTILITY(U,$J,358.3,29127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29127,1,4,0)
 ;;=4^Deep Phlebitis,Leg NEC
 ;;^UTILITY(U,$J,358.3,29127,1,5,0)
 ;;=5^451.19
 ;;^UTILITY(U,$J,358.3,29127,2)
 ;;=^269812
 ;;^UTILITY(U,$J,358.3,29128,0)
 ;;=451.81^^183^1854^49
 ;;^UTILITY(U,$J,358.3,29128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29128,1,4,0)
 ;;=4^Iliac Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,29128,1,5,0)
 ;;=5^451.81
 ;;^UTILITY(U,$J,358.3,29128,2)
 ;;=^269814
 ;;^UTILITY(U,$J,358.3,29129,0)
 ;;=454.0^^183^1854^52
 ;;^UTILITY(U,$J,358.3,29129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29129,1,4,0)
 ;;=4^Leg Varicosity w/ Ulcer
 ;;^UTILITY(U,$J,358.3,29129,1,5,0)
 ;;=5^454.0
 ;;^UTILITY(U,$J,358.3,29129,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,29130,0)
 ;;=454.1^^183^1854^51
 ;;^UTILITY(U,$J,358.3,29130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29130,1,4,0)
 ;;=4^Leg Varicosity w/ Inflam
 ;;^UTILITY(U,$J,358.3,29130,1,5,0)
 ;;=5^454.1
 ;;^UTILITY(U,$J,358.3,29130,2)
 ;;=^125435
 ;;^UTILITY(U,$J,358.3,29131,0)
 ;;=454.2^^183^1854^94
 ;;^UTILITY(U,$J,358.3,29131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29131,1,4,0)
 ;;=4^Varicos Leg Ulcer/Inflam
 ;;^UTILITY(U,$J,358.3,29131,1,5,0)
 ;;=5^454.2
 ;;^UTILITY(U,$J,358.3,29131,2)
 ;;=^269821
 ;;^UTILITY(U,$J,358.3,29132,0)
 ;;=454.9^^183^1854^16
 ;;^UTILITY(U,$J,358.3,29132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29132,1,4,0)
 ;;=4^Asymptomatic Varicose Veins
 ;;^UTILITY(U,$J,358.3,29132,1,5,0)
 ;;=5^454.9
 ;;^UTILITY(U,$J,358.3,29132,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,29133,0)
 ;;=459.81^^183^1854^97
 ;;^UTILITY(U,$J,358.3,29133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29133,1,4,0)
 ;;=4^Venous Insufficiency NOS
 ;;^UTILITY(U,$J,358.3,29133,1,5,0)
 ;;=5^459.81
 ;;^UTILITY(U,$J,358.3,29133,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,29134,0)
 ;;=457.1^^183^1854^56
 ;;^UTILITY(U,$J,358.3,29134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29134,1,4,0)
 ;;=4^Lymphedema,Other
 ;;^UTILITY(U,$J,358.3,29134,1,5,0)
 ;;=5^457.1
